PRIMARY FALLOPIAN TUBE CARCINOMA: A CASE REPORT AND CLINICAL REVIEW
MedPeer publisher · 2026
DOI: 10.70780/medpeer.000qgus ↗Kurz gefasst
Fallbericht in der Zeitschrift MedPeer publisher, 2026. Verfasst von Mohamed Fadil und 5 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Primary fallopian tube carcinoma (PFTC) is a rare gynecological malignancy that shares clinical behavior and molecular origins with high-grade serous ovarian carcinoma [1, 2]. Due to its non-specific clinical presentation and frequent overlap with primary ovarian masses, preoperative diagnosis remains exceptionally challenging [2, 3]. We present the clinical case of a 62-year-old female admitted for the evaluation of chronic, intermittent left lower quadrant pelvic pain. While initial ultrasonography suggested a suspicious ovarian mass, multi-parametric pelvic magnetic resonance imaging (MRI) demonstrated a solid tissue mass within a dilated left fallopian tube, demonstrating heterogeneous T2 signal intensity, restricted diffusion, and prominent post-contrast enhancement. This report highlights the key multi-parametric MRI features capable of identifying primary intra-fallopian tube neoplasms prior to surgical exploration, emphasizing the critical role of advanced imaging in guiding tailored primary surgical staging [3, 4].
Zitieren
APA
Fadil, M., Salmane, M., Guennouni, A., Saouab, R., Fenni, J. E., & Toufga, Z. (2026). PRIMARY FALLOPIAN TUBE CARCINOMA: A CASE REPORT AND CLINICAL REVIEW. MedPeer publisher. https://doi.org/10.70780/medpeer.000qgus
Vancouver
Fadil M, Salmane M, Guennouni A, Saouab R, Fenni JE, Toufga Z. PRIMARY FALLOPIAN TUBE CARCINOMA: A CASE REPORT AND CLINICAL REVIEW. MedPeer publisher. 2026. doi:10.70780/medpeer.000qgus
BibTeX
@article{Fadil2026,
author = {Fadil, Mohamed and Salmane, Mehdi and Guennouni, Asmae and Saouab, Rachida and Fenni, Jamal El and Toufga, Zakaria},
title = {PRIMARY FALLOPIAN TUBE CARCINOMA: A CASE REPORT AND CLINICAL REVIEW},
journal = {MedPeer publisher},
year = {2026},
doi = {10.70780/medpeer.000qgus}
}
EUVIMED